InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating

Sep.20.2025
InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
At InterTabac 2025, Germany’s leading distributor E-ZIGARETTEN-HANDELDE again centered its exhibit on ELFBAR, keeping the same booth location and visual identity as in previous years, and handing out tote bags at the hall entrance—creating “walking billboards.” The display focused primarily on open-system products, complemented by pod systems and e-liquids, plus a small selection of open-system lines from other brands.

2Firsts, Dortmund, September 2025 — At InterTabac 2025, leading local distributor E-ZIGARETTEN-HANDELDE returned as an exhibitor, once again appearing as a primary agent for ELFBAR. As in previous years, the booth kept the same location and overall design, maintaining strong visual identity.

 

The company also continued its habit of handing out tote bags at the venue entrance; on site, many passersby were seen carrying them—turning into “walking billboards.”

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Bags|Image:2Firsts

 

E-ZIGARETTEN-HANDELDE’s display centered on ELFBAR products, showcasing open-system devices, pod systems, and e-liquids, alongside a selection of open-system lines from other brands.

 

Overall, the portfolio skewed toward open-system products.

 

Below is the E-ZIGARETTEN-HANDELDE exhibit gallery.
 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Booth|Image:2Firsts


 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
E-ZIGARETTEN-HANDELDE Products|Image:2Firsts

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
North Carolina Tightens Vape Product Directory Enforcement, Expands State and Local Powers as Violators Face Fines, Product Seizures and License Suspension or Revocation
North Carolina Tightens Vape Product Directory Enforcement, Expands State and Local Powers as Violators Face Fines, Product Seizures and License Suspension or Revocation
North Carolina has expanded enforcement of its vapor product directory rules, authorizing more state and local law enforcement participation and establishing a task force led by the State Bureau of Investigation. The legislation requires at least one unannounced compliance inspection annually for retailers, distributors and wholesalers handling covered products. Penalties effective October 1, 2026, include civil fines of $500–$750 for a first violation and $1,000–$1,500 for repeated violations within 12 months, along with potential license suspension or revocation. Manufacturers may face penalties of $10,000 per unlisted product. The measures strengthen the product directory system established in 2024.
Regulations
Oct.28
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania Lists 163 Vape Products Eligible for Sale, Including Vuse and JUUL; Previously Pending Chinese Brands Such as OXBAR Remain Absent, While Unlisted Products Including Geek Bar Face Enforcement From October 19
Pennsylvania begins enforcing its electronic nicotine delivery system (ENDS) directory restrictions on October 19, 2026. The October 18 directory contained 163 product records from seven manufacturers, including Vuse, JUUL, NJOY, Logic and Naked 100. Geek Bar, RAZ and Lost Mary were absent. BAT, Altria, Japan Tobacco and JUUL collectively accounted for 112 records, or 68.7%, while Imperial Brands' blu had no listings. The directory included 15 disposable vape records, 40 bottled e-liquids and 10 products labeled 0mg, but no open-system refillable devices. Twenty-two manufacturer certifications remained under review. Four Logic models corresponding to Smoore's pending records were listed under the brand owner, while LYCO, OXBAR and Boulder/Rock had no approved directory entries.
Regulations
Oct.19
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08